top of page

Values in Rs. in  Crores

JUBILANT PHARMOVA Sep 23 Revenue as compared to Sep,22 Zooms by 5.1% to Rs.1680 Crore and Year on Year Profit zooms by 1162.2% to Rs.62 Crore. Quarter to Quarter Revenue Zooms by 5.9% and Q to Q Profit spikes by 935.0%

00:00 / 04:24
download (4).png

Revenue Analysis:

JUBILANT PHARMOVA, has reported a revenue of Rs. 1680 Crore, which has increases by 5.9% as compared to previous quarter revenue of Rs. 1587 Crore. As compared to revenue of September-22, there is a rise by 5.1% from Rs. 1600 Crore. to Rs. 1680 Crore.


Market Expectations V/s Actual

The Market Estimate of the Revenue was Rs.1749 Crore . Company's reported Revenue of Rs. 1680 is fairly in line with expectations.


Segment Revenue and Analysis

The Major Segments have been, Allergy Immunotherapy ,Contract Research,Contract Devlopment and Radiopharma. The share of each major segments are Allergy Immunotherapy : 180 Crore [10.7%] ,Contract Research : 289 Crore [17.2%],Contract Devlopment : 315 Crore [18.7%] and Radiopharma : 741 Crore [44.1%].


Profit and Cost Analysis

Quarterly Profit has flies by 1162.2% to Rs.62 Crore from Rs. 5 Crore, when compared with year ago quarter results. In comparison with preceding quarter of June, 2023 , quarter profit has zooms by 935.0% to Rs.62 Crore from Rs. 6 Crore. Net Profit % of the Company has remained at 3.7% compared to 0.4% in previous quarter and 0.3% in year ago quarter.


On analysis, it is observed that this Quarter's EBITDA (Operating Profit) Margin has increases to 14.4% from 10.7% as compared with June, 2023 quarter. The reason for the grown of EBITDA Margin is due to,

a) Cost of Sales has nearly stays similar to 33.2% (Previous Quarter: 32.8%). Cost of Sales in absolute terms has rise from Rs. 520 Crore to 557 Crore.

b) Employee Cost has shrinks to 31.6% (Previous Quarter: 34.5%). Employee Cost in exact value has dwindle from Rs. 548 Crore to 532 Crore.

c) Other Expenses has slip to 20.8% (Previous Quarter: 22.0%). Other Expenses nearly remain flat from Rs. 350 Crore to 349 Crore.


The finance cost has increases from Rs. 61.9 Crore to 66.1 Crore by 6.8%.


Share Price Movement:

The Return on Share Prices were -9.3% in past one month, 4.6% in 3 months, 26.6% in 6 months, 7.6% in 12 months, -33.8% in 24 months.


Summary:

To summarize, as compared to June'23, Revenue has zooms by 5.9%. Gross Margin has nearly remains regular from 67.2% to 66.8%. EBITDA Margin has increases to 14.4% from 10.7%. and Net Profit After Tax Margin has zooms to 3.7% from 0.4%.


The Brief of Quarterly Results is as follows:

JUBILANT PHARMOVA LIMITED

Particulars (In Cr.)
Sep, 2023
Jun, 2023
Mar, 2023
Dec, 2022
Revenue
1680
1587
1678
1553
Cost of Goods Sold
557
520
530
478
Employee Cost
532
548
534
568
Other Expenses
349
350
395
361
EBITDA
242
170
219
146
Depreciation
97
90
271
94
Interest Expense
66
62
56
51
Other Income
19
7
21
8
Profit B4 Excep. Items
98
25
-86
9
Exception Items
0
0
0
0
Net Profit Before Tax
98
25
-86
9
Taxes
36
19
14
25
Net Profit After Tax
62
6
-101
-16
Gross Margin %
66.80%
67.20%
68.40%
69.20%
Employee Cost %
31.60%
34.50%
31.80%
36.60%
Other Expense Cost %
20.80%
22.00%
23.50%
23.20%
EBITDA %
14.40%
10.70%
13.10%
9.40%
Net Profit After Tax %
3.70%
0.40%
-6.00%
-1.00%

Blue Dart Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.1% to Rs.1324 Crore and Year on Year Profit turndowns by 22.0% to Rs.73 Crore. Quarter to Quarter Revenue Surge by 7.0% and Q to Q Profit increases sharply by 19.2%

00:00 / 03:44

Reliance Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.9% to Rs.234956 Crore and Year on Year Profit flies by 28.2% to Rs.19878 Crore. Quarter to Quarter Revenue Surge by 11.4% and Q to Q Profit grown by 8.9%

00:00 / 03:57

Cipla Sep'23 Revenue as compared to Sep'22 Zooms by 14.6% to Rs.6678 Crore and Year on Year Profit zooms by 44.8% to Rs.1155 Crore. Quarter to Quarter Revenue Balloons by 16.4% and Q to Q Profit spikes by 121.4%

00:00 / 04:07

Maruti Suzuki Sep 23 Revenue as compared to Sep,22 Jumps by 23.8% to Rs.37073 Crore and Year on Year Profit flies by 78.2% to Rs.3764 Crore. Quarter to Quarter Revenue Surge by 14.6% and Q to Q Profit increases sharply by 49.1%

00:00 / 04:10

D-Link (India) Sep 23 Revenue as compared to Sep,22 Surge by 4.9% to Rs.308 Crore and Year on Year Profit increases by 4.2% to Rs.24 Crore. Quarter to Quarter Revenue Surge by 2.8% and Q to Q Profit grown by 12.9%

00:00 / 02:59
bottom of page